BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1618989)

  • 1. Influence of operating parameters on the preparative gradient elution chromatography of insulins.
    Cox GB
    J Chromatogr; 1992 May; 599(1-2):195-203. PubMed ID: 1618989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental models for optimization of insulin separation on reversed phase columns.
    Dimov N; Simeonov S
    Biomed Chromatogr; 1994; 8(1):32-6. PubMed ID: 8130631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separation of human, bovine, and porcine insulins, three very closely related proteins, by micellar electrokinetic chromatography.
    Lamalle C; Roland D; Crommen J; Servais AC; Fillet M
    Electrophoresis; 2015 Oct; 36(19):2504-6. PubMed ID: 26095856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separation of biological variant insulin molecules from different species by reversed-phase high-performance liquid chromatography (HPLC).
    Kalant D; Crawhall JC; Posner BI
    Biochem Med; 1985 Oct; 34(2):230-40. PubMed ID: 3910033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semi-preparative high-performance reversed-phase displacement chromatography of insulins.
    Vigh G; Varga-Puchony Z; Szepesi G; Gazdag M
    J Chromatogr; 1987 Jan; 386():353-62. PubMed ID: 3549752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-performance liquid chromatography of insulin.
    McLeod A; Wood SP
    J Chromatogr; 1984 Mar; 285(2):319-31. PubMed ID: 6371034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A parallel pore and surface diffusion model for predicting the adsorption and elution profiles of lispro insulin and two impurities in gradient-elution reversed phase chromatography.
    Chung PL; Bugayong JG; Chin CY; Wang NH
    J Chromatogr A; 2010 Dec; 1217(52):8103-20. PubMed ID: 21074775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fast optimization of stepwise gradient conditions for ternary mobile phase in reversed-phase high performance liquid chromatography].
    Shan YC; Zhang YK; Zhao RH
    Se Pu; 2002 Jul; 20(4):289-94. PubMed ID: 12541907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doping control analysis of insulin and its analogues in equine plasma by liquid chromatography-tandem mass spectrometry.
    Ho EN; Wan TS; Wong AS; Lam KK; Stewart BD
    J Chromatogr A; 2008 Aug; 1201(2):183-90. PubMed ID: 18501368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversed-phase high-performance liquid chromatography of insulins from different species.
    Rivier J; McClintock R
    J Chromatogr; 1983 Sep; 268(1):112-9. PubMed ID: 6355135
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of pore structural parameters on column performance and resolution of reversed-phase monolithic silica columns for peptides and proteins.
    Skudas R; Grimes BA; Machtejevas E; Kudirkaite V; Kornysova O; Hennessy TP; Lubda D; Unger KK
    J Chromatogr A; 2007 Mar; 1144(1):72-84. PubMed ID: 17084406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Packings and stationary phases in preparative column liquid chromatography.
    Unger KK; Janzen R
    J Chromatogr; 1986 Nov; 373(2):227-64. PubMed ID: 3805228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Column-friendly reversed-phase high-performance liquid chromatography of peptides and proteins using formic acid with sodium chloride and dynamic column coating with crown ethers.
    Poll DJ; Harding DR
    J Chromatogr; 1991 Feb; 539(1):37-45. PubMed ID: 1826504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [High performance liquid chromatography of protein. IV. Separation of insulin from different species (equine, porcine, bovine and ovine) by reversed phase high performance liquid chromatography (author's transl)].
    Asakawa N; Tsuno M; Saeki Y; Matsuda M; Hattori T; Ueyama M; Shinoda A; Miyake Y
    Yakugaku Zasshi; 1982 Jan; 102(1):43-8. PubMed ID: 7045327
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of insulin variants in patients with hyperinsulinemia by reversed-phase, high-performance liquid chromatography.
    Seino S; Funakoshi A; Fu ZZ; Vinik A
    Diabetes; 1985 Jan; 34(1):1-7. PubMed ID: 3880547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological potency of porcine, bovine and human insulins in the rabbit bioassay system.
    Pingel M; Vølund A; Sørensen E; Collins JE; Dieter CT
    Diabetologia; 1985 Nov; 28(11):862-9. PubMed ID: 3910496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the optimum performance of the different modes of preparative liquid chromatography.
    Felinger A; Guiochon G
    J Chromatogr A; 1998 Feb; 796(1):59-74. PubMed ID: 9513282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doping control analysis of insulin and its analogues in equine urine by liquid chromatography-tandem mass spectrometry.
    Ho EN; Wan TS; Wong AS; Lam KK; Stewart BD
    J Chromatogr A; 2011 Feb; 1218(8):1139-46. PubMed ID: 21256494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large scale purification and characterization of A21 deamidated variant-most prominent post translational modification (PTM) for insulins which is also widely observed in insulins pharmaceutical manufacturing and storage.
    Shukla V; Srivatsa K; Madhu Kumar MS; Vajpai N; Agarwal N; Nethra S; Somesh BP; Kulshrestha A; Hazra P
    Protein Expr Purif; 2021 Sep; 185():105895. PubMed ID: 33957255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling and optimization of preparative reversed-phase liquid chromatography for insulin purification.
    Degerman M; Jakobsson N; Nilsson B
    J Chromatogr A; 2007 Aug; 1162(1):41-9. PubMed ID: 17376466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.